Basal Septal Hypertrophy

A significant clinical problem is patients presenting with exercise-limiting dyspnoea, sometimes with associated chest pain, in the absence of detectable left ventricular (LV) systolic dysfunction, coronary artery disease, or lung disease. Often the patients are older, female, and have isolated basa...

Full description

Saved in:
Bibliographic Details
Published inCurrent cardiology reviews Vol. 9; no. 4; pp. 325 - 330
Main Authors Kelshiker, Mihir A, Mayet, Jamil, Unsworth, Beth, Okonko, Darlington O
Format Journal Article
LanguageEnglish
Published United Arab Emirates Bentham Science Publishers Ltd 01.11.2013
Subjects
Cardiomyopathy, Hypertrophic - diagnostic imaging
Diastole - physiology
Dyspnea - etiology
Heart Septum - diagnostic imaging
Heart Septum - pathology
Humans
Hypertrophy - diagnostic imaging
Hypertrophy - etiology
Hypertrophy - physiopathology
Stroke Volume - physiology
Systole - physiology
Ultrasonography
Online AccessGet full text

Cover

More Information
Summary:A significant clinical problem is patients presenting with exercise-limiting dyspnoea, sometimes with associated chest pain, in the absence of detectable left ventricular (LV) systolic dysfunction, coronary artery disease, or lung disease. Often the patients are older, female, and have isolated basal septal hypertrophy (BSH), frequently on a background of mild hypertension. The topic of breathlessness in patients with clinical heart failure, but who have a normal ejection fraction (HFNEF) has attracted significant controversy over the past few years. This review aims to analyse the literature on BSH, identify the possible associations between BSH and HFNEF, and consequently explore possible pathophysiological mechanisms whereby clinical symptoms are experienced.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1573-403X
1875-6557
DOI:10.2174/1573403X09666131202125424